Oura valued at $5B following deal with medical device firm Dexcom | TechCrunch

Smart ring maker Oura gets $75M investment from Dexcom, valuing company at over $5B.

Oura Deal Announced

The partnership will allow Oura rings to help users monitor their blood sugar by integrating with Dexcom glucose devices.

Partnership Details

Download App

Oura has sold over 2.5M rings and expects 2024 sales to double to around $500M while being profitable.

Growth and Profitability

Download App

Apple is also working on noninvasive glucose monitoring, though it's unclear if the company plans to release a related product.

Competition from Apple

Download App